The Center for Cancer and Hematologic Disease — Cherry Hill, New Jersey

The Center for Cancer and Hematologic Disease is a clinical research site located in Cherry Hill, New Jersey, United States 08003.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

The Center for Cancer and Hematologic Disease has participated in 15 clinical trials.

Therapeutic areas: Tumors, Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Mateon Therapeutics, Morphotek, Celgene.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Center for Cancer and Hematologic Disease?

The Center for Cancer and Hematologic Disease has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Center for Cancer and Hematologic Disease conducted?

The Center for Cancer and Hematologic Disease has 15 clinical trials on record. Their work covers Tumors, Ovarian Cancer, Fallopian Tube Cancer.

Is The Center for Cancer and Hematologic Disease accredited by Crixeo Health?

Yes — The Center for Cancer and Hematologic Disease holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Center for Cancer and Hematologic Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.